Gideon Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,655
Closed -$314K 462
2017
Q4
$314K Buy
+1,655
New +$317K 0.28% 152
2015
Q1
Sell
-2,855
Closed -$358K 304
2014
Q4
$358K Buy
+2,855
New +$347K 0.17% 149
2014
Q3
Sell
-3,427
Closed -$404K 366
2014
Q2
$404K Buy
+3,427
New +$403K 0.15% 177

Other funds holding TMO

Gideon Capital Advisors's TMO Position: Q1 2018 in Review

Gideon Capital Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2018, closing a stake of 1,655 shares — an estimated $314K sold.

Gideon Capital Advisors first reported a position in TMO in Q2 2014 and held it in 3 quarters. The position peaked at $404K in Q2 2014. 1,305 funds tracked by Wall St. Rank hold TMO as of Q1 2018.

  • Gideon Capital Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2018 after selling out during the quarter.
  • Gideon Capital Advisors sold 1,655 Thermo Fisher Scientific shares in Q1 2018, an estimated $314K.
  • Gideon Capital Advisors first reported a position in Thermo Fisher Scientific in Q2 2014 and held it in 3 quarters.
  • Gideon Capital Advisors's Thermo Fisher Scientific position peaked at $404K in Q2 2014.
  • 1,305 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2018.

Based on Gideon Capital Advisors's 13F filing for Q1 2018, filed 14 May 2018.